|
| Press Releases |
|
 |
|
| Tuesday, September 3, 2024 |
|
|
The 18th Frost & Sullivan Growth, Innovation and Leadership Summit, China: A Huge Success |
| The 18th Frost & Sullivan Growth, Innovation and Leadership Summit and the 3rd New Investment Event (NIE 2024), was held in Shanghai from August 27-30, 2024, co-hosted by LeadLeo. more info >> |
|
|
2024沙利文新投資大會圓滿閉幕：凝新聚力，質贏未來 |
| 由弗若斯特沙利文（Frost & Sullivan，簡稱：“沙利文”）主辦，頭豹協辦的2024第十八届沙利文中國增長、科創與領導力峰會暨第三届新投資大會於8月28日-8月30日在上海靜安瑞吉酒店成功舉辦。 more info >> |
|
|
2024沙利文新投资大会圆满闭幕：凝新聚力，质赢未来 |
| 由弗若斯特沙利文（Frost & Sullivan，简称：“沙利文”）主办，头豹协办的2024第十八届沙利文中国增长、科创与领导力峰会暨第三届新投资大会于8月28日-8月30日在上海静安瑞吉酒店成功举办。 more info >> |
|
| Wednesday, July 8, 2020 |
|
|
Frost & Sullivan Honors Leading Organizations in Asia-Pacific in an Inaugural Virtual Ceremony for the 2020 Asia-Pacific Best Practices Awards |
| Frost & Sullivan honored Asia-Pacific's leading companies at the 18th annual Asia-Pacific Best Practices Awards on 8 July in an inaugural virtual awards ceremony. more info >> |
|
| Friday, March 3, 2017 |
|
|
Frost＆Sullivan的最新研究顯示亞洲是臨床試驗的首選地 |
Frost＆Sullivan今天發布了其與亞太專家CRO Novotech合作的最新白皮書“亞洲：臨床試驗的首選地”。新白皮書的研究表明，由於擁有大量無治療效果的患者庫，特殊的臨床基礎設施和人才，以及較低的運營成本，亞洲正迅速成為臨床研究的主力軍。
more info >> |
|
|
Frost＆Sullivan的最新研究显示亚洲是临床试验的首选地 |
Frost＆Sullivan今天发布了其与亚太专家CRO Novotech合作的最新白皮书“亚洲：临床试验的首选地”。新白皮书的研究表明，由于拥有大量无治疗效果的患者库，特殊的临床基础设施和人才，以及较低的运营成本，亚洲正迅速成为临床研究的主力军。
more info >> |
|
|
New Frost & Sullivan research reveals Asia as Preferred Destination for Clinical Trials |
| Frost & Sullivan released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with Asia Pacific specialist CRO Novotech. Research from the new white paper revealed Asia is quickly becoming a clinical research powerhouse. more info >> |
|
| Wednesday, June 25, 2014 |
|
|
Fast-Evolving US Cardiac Ablation Industry Affords Multiplying Niche Opportunities, Says Frost & Sullivan |
| Recent analysis from Frost & Sullivan's Analysis of the US Cardiac Ablation Market finds the market earned revenue of $2.77 billion in 2013 and estimates this to reach $5.75 billion in 2020. The analysis covers catheter ablation, surgical ablation and cardiac mapping. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Tat Hong Equipment Service Co., Ltd. Announces 2024/25 Interim Results
Nov 22, 2024 19:56 HKT/SGT
|
|
|
达丰设备服务有限公司 公布2024/25中期业绩
Nov 22, 2024 19:35 HKT/SGT
|
|
|
達豐設備服務有限公司 公佈2024/25中期業績
Nov 22, 2024 19:18 HKT/SGT
|
|
|
Mailbird Expands to Mac: Popular Windows Email Client Launches Much-Anticipated Mac App
Nov 22, 2024 18:30 HKT/SGT
|
|
|
CleverTap Recognized as a 'Strong Performer' in the Cross-Channel Marketing Hubs, Q4 2024 Report
Nov 22, 2024 17:42 JST
|
|
|
DesignInspire opens on December 5, with free admission for the public
Nov 22, 2024 15:30 HKT/SGT
|
|
|
neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Nov 22, 2024 15:00 HKT/SGT
|
|
|
透雲生物萊茵衣藻獲國家衛健委新用途許可
Nov 22, 2024 14:42 HKT/SGT
|
|
|
透云生物莱茵衣藻获国家卫健委新用途许可
Nov 22, 2024 14:41 HKT/SGT
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 12:00: JST
|
|
|
Daeshin MC Co., Ltd.は、産業現場から公共施設まで快適な室内環境を作り出すクリーンソリューションを発表
Nov 22, 2024 12:00: JST
|
|
|
三菱重工、新たな防衛輸送用「機動舟艇」に搭載するウォータージェット推進装置の供給へ
Nov 22, 2024 11:45: JST
|
|
|
Daeshin MC Co., Ltd. Unveils Its Clean Solutions Creating Pleasant Indoor Environments from Industrial Sites to Public Facilities
Nov 22, 2024 11:00 HKT/SGT
|
|
|
Jacobson Pharma Announces FY2025 Interim Results
Nov 22, 2024 10:00 HKT/SGT
|
|
|
雅各臣公佈二零二五財年中期業績 持續經營業務溢利飈升44.2%
Nov 22, 2024 10:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
